ApprovalTrail

Approval · Notice of Compliance 22769 · 2019

TRULANCE: Notice of Compliance 22769

Issued October 10, 2019

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
22769
Date
October 10, 2019
Company
Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
New Active Substance (NAS)

Products in this notice

BrandDINStatus today
TRULANCE02493012Marketed

Medicinal ingredients